Promega Launches Sanger Sequencing Chemistry Compatible With All Capillary Electrophoresis Platforms
MADISON, Wis.--(BUSINESS WIRE)--Research labs performing Sanger sequencing can now use Promega chemistry on any capillary electrophoresis (CE) platform. The ProDyeâ„¢ Terminator Sequencing System, ...
In this interview, News Med is talking to Gabriela Saldanha about DNA Fragmentation and Sanger Sequencing. What are Sanger sequencing and DNA-fragment analysis? Where are these analyses used? Sanger ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Capillary electrophoresis (CE), which enables Sanger sequencing and fragment analysis, is an important tool for improving clinical research and advancing scientific ...
Due to its high accuracy and fast, simple workflow, capillary electrophoresis (CE) is a foundational technology for clinical applications. CE is an invaluable tool used to detect genetic variations ...
In 1997, Sanger, Nicklen and Coulson described a method for determining DNA nucleotide sequences. 1 Nearly five decades later, Sanger sequencing remains an entrenched technology for targeted ...
In this Tech Blast episode, Jay Lemke, Senior Research Scientist at Promega, provides a brief overview of Sanger sequencing, its history, working principle and development over the last half century.
Sanger sequencing has been the powerhouse of DNA sequencing since it was invented by Frederick Sanger in 1977, a creation for which he won his second Nobel Prize in Chemistry in 1980. There have been ...
Due to its high accuracy and fast, simple workflow, capillary electrophoresis (CE) is a foundational technology for clinical applications. CE is an invaluable tool used to detect genetic variations ...
This image compares three DNA sequencing technologies: Sanger sequencing, Massively Parallel DNA sequencing, and Nanopore DNA sequencing. Sanger sequencing (left) sequences 500-700 bases per reaction ...
News-Medical.Net on MSN
Study validates OVCAR3 as a model for high-grade serous ovarian cancer
A new research paper was published in Volume 12 of Oncoscience on October 14, 2025, titled "Bridging clinical insight and laboratory model in high-grade serous ovarian carcinoma (HGSOC) using DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results